ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場：タイプ、コンポーネント、エンドユーザー、展開別-2025-2030年世界予測

ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場は、2023年に66億2,000万米ドルと評価され、2024年には80億7,000万米ドルに達すると予測され、CAGR 22.79％で成長し、2030年には278億7,000万米ドルに達すると予測されています。

ヘルスケアとライフサイエンスにおけるペイシェントマネジメントは、初診から診断、治療、フォローアップケアに至るまで、患者の体験を包括的に追跡し最適化する患者パスウェイの開発と強化を広く包含しています。その必要性は、個別化されたヘルスケア体験、患者転帰の改善、ヘルスケア提供システムにおけるコスト効率に対する需要の高まりに起因しています。アプリケーションは多様で、病院管理、患者エンゲージメント・プラットフォーム、遠隔医療から電子カルテ、医薬品サービスまで多岐にわたる。最終用途の範囲には、業務効率と患者満足度の最適化を目指す病院、診療所、製薬会社、保険プロバイダーが含まれることが多いです。主な市場成長要因としては、AIや機械学習などの技術的進歩、ヘルスケアのデジタル化の進展、患者データをリアルタイムで追跡するウェアラブル医療機器の採用増加などが挙げられます。潜在的なビジネスチャンスは、シームレスでパーソナライズされた患者の旅を提供するための先進技術の統合や、サービス提供とリーチを拡大するための戦略的パートナーシップの形成にあります。しかし、データのプライバシーに関する懸念、ヘルスケア規制の複雑さ、高度な旅程管理システムの普及を阻害する高い導入コストなどの制約があります。さらに、相互運用性の問題を克服し、既存のヘルスケア・インフラとのシームレスな統合を確保することは、依然として課題となっています。患者のニーズをより的確に予測するための予測分析の改善や、患者データを保護しながら相互運用性を高めるソリューションの開発には、イノベーションの機会が存在します。AI主導の個別化医療、効果的な慢性疾患管理、強化されたバーチャルケアプラットフォームの調査も、事業成長の大きな道筋を示します。市場は急速な技術進化と競合力学を特徴としており、俊敏性、継続的イノベーション、新興手法の採用の重要性が強調されています。企業は競争力を維持するため、堅牢なデータ管理戦略と、ヘルスケア提供における消費者中心の動向の進展に対応した拡張性の高いソリューションの開発に投資することが推奨されます。

市場力学：急速に進化するヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場の主要市場インサイトを公開

ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ヘルスケア・ジャーニー全体を通して一貫したペイシェント・エクスペリエンスの必要性
  • ライフサイエンスの商業化において、患者ジャーニーを詳細に把握する必要性
  • 患者中心のサービスへの劇的なシフト
• 市場抑制要因
  • データ同期に伴う複雑さ
• 市場機会
  • デジタル化により、仮想タッチポイントでの顧客とのインタラクションが増加
  • 患者の意思に関する高度なアナリティクスの採用拡大
• 市場の課題
  • 旅程管理ソリューションにおけるデータプライバシーとセキュリティの懸念

ポーターの5つの力：ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場における外部からの影響の把握

外部マクロ環境要因は、ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場における競合情勢の把握

ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場における成功への道筋を描く

ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ヘルスケア過程全体を通じて一貫した患者体験の必要性
    • ライフサイエンスの商業化におけるペイシェントジャーニーを詳細に把握したいという要望
    • 患者中心のサービスへの劇的な転換
  • 抑制要因
    • データ同期に伴う複雑さ
  • 機会
    • デジタル化により仮想タッチポイントでの顧客とのやり取りが増加
    • 患者の意図に関する高度な分析の導入が増加
  • 課題
    • 旅程管理ソリューションにおけるデータプライバシーとセキュリティの懸念
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場：タイプ別

• 保険ジャーニー管理
• ペイシェントジャーニー管理
• 製品ライフサイクル管理

第7章 ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場：コンポーネント別

• ジャーニー分析
• ジャーニーマッピング
• 旅のオーケストラ

第8章 ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場：エンドユーザー別

• ヘルスケア患者
• 医療費支払者
• 医療提供者
• 製薬・バイオテクノロジー企業

第9章 ヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場：展開別

• クラウド上
• オンプレミス

第10章 南北アメリカのヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのヘルスケア＆ライフサイエンスにおけるジャーニーマネジメント市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Acoustic, L.P
• Acxiom Ltd.
• Applied Epic
• Arena Solutions
• AthenaHealth
• Cisco Systems, Inc.
• eClinicalWorks
• Indicative, Inc.
• InSync Healthcare Solutions
• Luma Health
• MasterControl
• NextGen Healthcare
• NICE Systems Inc.
• Oracle Corporation
• Pegasystems Inc.
• Quadient SA
• Salesforce.com, inc.
• SAP SE
• Servion Global Solutions Ltd.
• Vertafore, Inc.

LIST OF FIGURES

• FIGURE 1. JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET RESEARCH PROCESS
• FIGURE 2. JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET DYNAMICS
• TABLE 7. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY INSURANCE JOURNEY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PATIENT JOURNEY MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PRODUCT LIFECYCLE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY ANALYTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY MAPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY JOURNEY ORCHISTRATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PATIENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PAYER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY HEALTHCARE PROVIDER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 36. CANADA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 38. CANADA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. CANADA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 58. CHINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 60. CHINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. CHINA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 62. INDIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 64. INDIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. INDIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 131. ITALY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 133. ITALY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. ITALY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 147. POLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 149. POLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. POLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 151. QATAR JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 153. QATAR JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. QATAR JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
• TABLE 191. JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. JOURNEY MANAGEMENT IN HEALTHCARE & LIFE SCIENCES MARKET, FPNV POSITIONING MATRIX, 2023

The Journey Management in Healthcare & Life Sciences Market was valued at USD 6.62 billion in 2023, expected to reach USD 8.07 billion in 2024, and is projected to grow at a CAGR of 22.79%, to USD 27.87 billion by 2030.

Journey management in healthcare and life sciences broadly encompasses the development and enhancement of patient pathways, which involve the comprehensive tracking and optimization of patient experiences from initial contact through diagnosis, treatment, and follow-up care. Its necessity stems from the growing demand for personalized healthcare experiences, improved patient outcomes, and cost efficiency in healthcare delivery systems. Applications are diverse, ranging from hospital management, patient engagement platforms, and telemedicine to electronic health records and pharmaceutical services. The end-use scope often includes hospitals, clinics, pharmaceutical companies, and insurance providers seeking to optimize operational efficiency and patient satisfaction. Key market growth factors include technological advancements such as AI and machine learning, increasing healthcare digitization, and the rising adoption of wearable health devices that track patient data in real-time. Potential opportunities lie in integrating advanced technologies to provide a seamless and personalized patient journey, and in forming strategic partnerships to expand service offerings and reach. However, limitations include data privacy concerns, the complexity of healthcare regulations, and high implementation costs which can inhibit the widespread adoption of sophisticated journey management systems. Moreover, navigating interoperability issues and ensuring seamless integration with existing healthcare infrastructure remains a challenge. Innovation opportunities exist in improving predictive analytics to anticipate patient needs better and in developing solutions that enhance interoperability while safeguarding patient data. Research into AI-driven personalized medicine, effective chronic disease management, and enhanced virtual care platforms also presents significant avenues for business growth. The market is characterized by rapid technological evolution and competitive dynamics, emphasizing the importance of agility, continual innovation, and adoption of emerging methodologies. Companies are advised to invest in developing robust data management strategies and scalable solutions that cater to the advancing consumer-centric trends in healthcare delivery to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Journey Management in Healthcare & Life Sciences Market

The Journey Management in Healthcare & Life Sciences Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Need for consistent patient experience throughout the healthcare journey
  • Demand to gain granular view of the patient journey in life sciences commercialization
  • Dramatic shift towards patient-centric services
• Market Restraints
  • Complications associated with the data synchronization
• Market Opportunities
  • Digitalization increases customer interaction at virtual touchpoints
  • Growing adoption of advanced analytics on patient intents
• Market Challenges
  • Data privacy and security concerns with journey management solutions

Porter's Five Forces: A Strategic Tool for Navigating the Journey Management in Healthcare & Life Sciences Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Journey Management in Healthcare & Life Sciences Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Journey Management in Healthcare & Life Sciences Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Journey Management in Healthcare & Life Sciences Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Journey Management in Healthcare & Life Sciences Market

A detailed market share analysis in the Journey Management in Healthcare & Life Sciences Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Journey Management in Healthcare & Life Sciences Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Journey Management in Healthcare & Life Sciences Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Journey Management in Healthcare & Life Sciences Market

A strategic analysis of the Journey Management in Healthcare & Life Sciences Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Journey Management in Healthcare & Life Sciences Market, highlighting leading vendors and their innovative profiles. These include Acoustic, L.P, Acxiom Ltd., Applied Epic, Arena Solutions, AthenaHealth, Cisco Systems, Inc., eClinicalWorks, Indicative, Inc., InSync Healthcare Solutions, Luma Health, MasterControl, NextGen Healthcare, NICE Systems Inc., Oracle Corporation, Pegasystems Inc., Quadient SA, Salesforce.com, inc., SAP SE, Servion Global Solutions Ltd., and Vertafore, Inc..

Market Segmentation & Coverage

This research report categorizes the Journey Management in Healthcare & Life Sciences Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Insurance Journey Management, Patient Journey Management, and Product Lifecycle Management.
• Based on Component, market is studied across Journey Analytics, Journey Mapping, and Journey Orchistration.
• Based on End-User, market is studied across Healthcare Patient, Healthcare Payer, Healthcare Provider, and Pharmaceutical & Biotechnology Companies.
• Based on Deployment, market is studied across On-Cloud and On-Premises.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Need for consistent patient experience throughout the healthcare journey
    • 5.1.1.2. Demand to gain granular view of the patient journey in life sciences commercialization
    • 5.1.1.3. Dramatic shift towards patient-centric services
  • 5.1.2. Restraints
    • 5.1.2.1. Complications associated with the data synchronization
  • 5.1.3. Opportunities
    • 5.1.3.1. Digitalization increases customer interaction at virtual touchpoints
    • 5.1.3.2. Growing adoption of advanced analytics on patient intents
  • 5.1.4. Challenges
    • 5.1.4.1. Data privacy and security concerns with journey management solutions
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Journey Management in Healthcare & Life Sciences Market, by Type

• 6.1. Introduction
• 6.2. Insurance Journey Management
• 6.3. Patient Journey Management
• 6.4. Product Lifecycle Management

7. Journey Management in Healthcare & Life Sciences Market, by Component

• 7.1. Introduction
• 7.2. Journey Analytics
• 7.3. Journey Mapping
• 7.4. Journey Orchistration

8. Journey Management in Healthcare & Life Sciences Market, by End-User

• 8.1. Introduction
• 8.2. Healthcare Patient
• 8.3. Healthcare Payer
• 8.4. Healthcare Provider
• 8.5. Pharmaceutical & Biotechnology Companies

9. Journey Management in Healthcare & Life Sciences Market, by Deployment

• 9.1. Introduction
• 9.2. On-Cloud
• 9.3. On-Premises

10. Americas Journey Management in Healthcare & Life Sciences Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Journey Management in Healthcare & Life Sciences Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Journey Management in Healthcare & Life Sciences Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Acoustic, L.P
• 2. Acxiom Ltd.
• 3. Applied Epic
• 4. Arena Solutions
• 5. AthenaHealth
• 6. Cisco Systems, Inc.
• 7. eClinicalWorks
• 8. Indicative, Inc.
• 9. InSync Healthcare Solutions
• 10. Luma Health
• 11. MasterControl
• 12. NextGen Healthcare
• 13. NICE Systems Inc.
• 14. Oracle Corporation
• 15. Pegasystems Inc.
• 16. Quadient SA
• 17. Salesforce.com, inc.
• 18. SAP SE
• 19. Servion Global Solutions Ltd.
• 20. Vertafore, Inc.